Ignite Creation Date:
2024-07-17 @ 11:08 AM
Last Modification Date:
2024-10-26 @ 3:32 PM
Study NCT ID:
NCT06463522
Status:
RECRUITING
Last Update Posted:
2024-06-17
First Post:
2024-04-26
Brief Title:
Safety and Efficacy of Autologous Tumor-infiltrating Lymphocytes Therapy in Patients With Hepatocellular Carcinoma
Sponsor:
Beijing 302 Hospital
Organization:
Beijing 302 Hospital
Organization Data
Organization:
Beijing 302 Hospital
Class:
OTHER
Study ID:
KY-2024-3-48-2
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Beijing 302 Hospital
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None